Drug Approval | April 20, 2026
Aurobindo Pharma bags USFDA nod for Glycerol Phenylbutyrate Oral Liquid
The approved product is a generic version of Ravicti, originally developed and marketed by Horizon Therapeutics
The approved product is a generic version of Ravicti, originally developed and marketed by Horizon Therapeutics
PMDA is regarded among the most stringent regulatory bodies globally
The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation
The company stated that it will work closely with the regulator to address the observations within the stipulated timeframe
Collaboration integrates AJICAP™ technology with global manufacturing capabilities to streamline antibody-drug conjugate pipelines
This combination works to break down rough patches, improve moisture retention, and enhance overall skin texture
The company allocated €56 million to research and development for next-generation line solutions
Zero-observation outcomes strengthen global credibility and accelerate CDMO ambitions
Visit underscores push for self-reliance in essential medical consumables and India’s ambition to become a global medtech manufacturing hub
TheraNym will set up a greenfield large-scale mammalian drug substance manufacturing facility
Subscribe To Our Newsletter & Stay Updated
